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A B S T R A C T  
 
The spectrum of Clostridium perfringens infections ranges from food toxino-
sis to myonecrosis. In the current study, whole cell protein and toxin gene 
types were profiled in 12 randomly selected C. perfringens veterinary stock 
cultures from the University of Wisconsin, Madison to determine epidemio-
logical similarity, or diversity amongst strains of animal origin. Whole cell 
protein analysis was done by SDS-PAGE while toxin gene typing was achieved 
by extracting DNA by boiling, DNA concentration and purity was determined 
by spectrophotometer and nanodrop while separation was carried out by 
checking it on gel electrophoresis. Multiplex PCR was used to identify the 
toxigenic gene-type. C. perfringens B and C. perfringens EE with established 
profiles were used as control strains. Isolates typed included strains cp 296, 
309, 12872 (from dogs) and 304, 305, 306, 341, 342, 10754, 12218-2, 12218-
3, 12473 (from calves). All 12 strains possess the cpa gene, 4 strains have 
cpb2, 3 strains etx, 2 strains positive for cpe and 1 for cpb. None of the 
strains carries the itx gene. Two strains have only cpa gene however no 
strains has more than two toxin gene types, with cpa-cpb2 combination be-
ing more frequent. C. perfringens 305 (etx and cpa) and 342 (cpe and cpa) 
shared the same protein profile but belong to different toxinotype. It is evi-
dent that the cpa gene is a marker for all C. perfringens strains, and similarity 
in protein profile is not sine qua non for toxin gene type. 
1. Introduction 
Clostridium perfringens is an anaerobic Gram posi-
tive spore forming bacillus with the characteristic 
box car appearance. The bacilli produce lecithinase 
(alpha toxin) and on blood agar a double zone of 
hemolysis. The spectrum of C. perfringens diseases 
is the consequence of the secretion of extracellular 
toxins. Five major types of C. perfringens  (A, B, C, 
D and E) have been described based on toxin pro-
duction with types B, C and D associated most with 
disease in domestic animals (Songer and Miskimins, 
2005; Hendriksen et al., 2006; Ferrarezi et al., 
2008). Illnesses and death losses in baby calves 
caused by C. perfringens are significant problems 
for producers raising calves in beef or dairy opera-
tions (Daly and Rotert, 2007). Cattle ranching are 
usually free range in Nigeria and the nomadic 
herd’s men travel distance with their flocks. Death 
from these is usually due to fatigue or from trypa-
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nosomiasis for which vaccination cover is mandato-
ry. However not frequently reported is enterotox-
aemia associated with C. perfringens infection 
(Itodo and Ike, 1990; Itodo et al., 2009). Conse-
quently, not much has been done with respect to 
characterization of the toxin genes with the aid to 
facilitate diagnosis which through conventional 
methods is cumbersome.  
Alpha toxin gene (cpa) which encodes the CPA tox-
in is present in all C. perfringens strains and is chro-
mosomally located unlike other major toxin genes 
of C. perfringens which are plasmid borne (Cole 
and Canard, 1997; Li et al., 2007). The cpb gene 
which is carried on a virulent plasmid encodes CPB 
toxin. CPB is produced by types B and C of C. 
perfringens. Both types B and C animal disease are 
often accompanied by sudden death or acute neu-
rological signs (McClane et al., 2004; Uzal, 2004). 
The gene etx is located on a conjugative plasmid 
and encodes ETX; an aerolysin-like, pore-forming 
toxin considered the major virulence factor of C. 
perfringens types B and D (Sayeed et al., 2007). ETX 
producing C. perfringens type D strains are the 
most common cause of colitis in sheep and goats 
(Uzal and Kelly, 1997; Uzal 2004).  
Iota toxin (ITX) of C. perfringens toxinotype E has 
been implicated in hemorrhagic enteritis and sud-
den death in calves (Songer and Miskimins, 2005), 
but disease in sheep and goat is rare (Songer, 
1998). The cpb2 toxin gene is the next most fre-
quent after cpa in C. perfringens (Fisher et al., 
2006). The cpb2 gene is present on C. perfringens 
type D isolates and may be borne on the same plas-
mid carrying the etx gene or on a different plasmid 
(Sayeed et al., 2007). However, in type E isolates 
the cpb2 gene is always present on different plas-
mid carrying the itx gene (Li et al., 2007). CPB2 has 
been implicated in more animal disease both do-
mestic and wild including swine, cattle, horses, 
sheep, goats, deer and bears (Dray, 2004; Hen-
driksen et al., 2006; Ferrarezi et al., 2008; Jores et 
al., 2008). 
The gene cpe encoding CPE can reside on either the 
chromosome or on plasmids (Collie and McClane, 
1998). Most human food-poisoning isolates carry 
cpe on the chromosome (McClane et al., 2006), and 
are known to be divergent from other C. 
perfringens isolates (Deguchi et al., 2009). In con-
trast, cpe-positive isolates recovered from diseased 
animals or humans suffering from non-food-borne 
gastrointestinal disease carry cpe on large plasmids 
(Sparks et al., 2001). 
C. perfringens is ubiquitous and causes diseases in 
humans, domestic and wild animals. Though some 
C. perfringens types are more adapted to certain 
animals, nevertheless, infections with same type in 
multiple animals have been described. Further-
more, the conventional diagnosis protocol for C. 
perfringens include isolation of the bacilli from dis-
ease site, detection of one or more toxin types 
and/or determination of the presence of toxin 
genes. The pitfalls in presence of bacilli in specimen 
as diagnostic and the technical details and cost of 
assays for toxin make isolation and toxin detection 
cumbersome approaches in epidemiological stud-
ies. The objective of the present study therefore 
was to use PCR and other molecular techniques to 
determine the toxin gene type of C. perfringens 
isolated from clinically sick or diseased animals in 
line with whole cell protein profile first as a marker 
for the toxin type elaborated by the bacilli in the 
disease process and secondly to assess epidemio-
logical similarity or divergence in the animal iso-
lates. 
2. Materials and Methods 
2.1. Clostridium perfringens strains 
Twelve veterinary isolates of C. perfringens identi-
fied by conventional cultural, morphological and 
biochemical properties with strain numbers cp 296, 
309, 12872 (from dogs) and 304, 305, 306, 341, 
342, 10754, 12218-2, 12218-3, 12473 (from calves) 
and two reference strains of C. perfringens (strains 
Cp B and Cp EE) with known protein and gene pro-
files obtained from the stock culture collection of 
the Wisconsin Veterinary Diagnostics Laboratory of 
the Department of Pathobiological Sciences, Uni-
versity of Wisconsin were used in this study. Strains 
309 from dog and strains 305 and 342 from calves 
were isolated from dead animals. The strains were 
supplied by Professor Okwumabua Ogi of the Uni-
versity of Wisconsin, Madison, USA and maintained 
at -8oC. Before use, strains were sub-cultured on 
non-selective Brucella based blood agar plates and 
incubated in 5% and 10% CO2 for 48 h and colonies 
Gram stained to test for purity. Preliminary screen-
ing tests including double zones of b-hemolysis, 
box-car shaped bacilli and positive lecithinase 
(alpha toxin) activity confirmed the isolates. 
2.2. DNA extraction 
Pure culture of C. perfringens on Blood agar plates 
were harvested into 1.5 ml tube containing 200 ul 
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of water. The tube was boiled at 100 oC for 20 min 
to release the DNA, cooled at -20 oC for 10 min and 
then centrifuged at 13000 rpm for 2 min to concen-
trate the DNA. The DNA concentration and purity 
were determined by spectrophotometer (Model, D-
37520, Thermo Scientific, Waltham, Massachusetts, 
MA, USA) and nanodrop (Model, 2000, Thermo 
Scientific, Waltham, Massachusetts, MA, USA). The 
OD 260/280 reading of the purified DNA was >1.8. 
The concentration of DNA used was 50 ng/ul. 
2.3. PCR primers and amplification 
Primers for C. perfringens B and EE toxin genes itx, 
cpa, cpb, cpb2, cpe, and etx were used for the am-
plification and together with dNTP (dATP, dTTP, 
dGTP, dCTP), amplitaq, PCR buffer, divalent cation 
(Mg2+) and water constituted the master mix. PCR 
amplification was performed in a total volume of 
50 µl made up of water (24.3 µl), 1X PCR buffer (5.0 
µl), dNTP mix (2.4 µl of 0.48 µM), itx (1.3 µl of 0.52 
µM), cpa (1.25 µl of 0.50 µM), cpb (0.9 µl of 0.36 
µM), cpb2 (0.9 µl of 0.36 µM), cpe (0.85 µl of 0.34 
µM), etx (1.1 µl of 0.44 µM), amplitaq (1.0 µl of 5 
units), MgCl2 (1.0 µl of 0.55 µM) and 10 µl of DNA. 
The negative control contains 10 µl of DNA free 
water in place of the test DNA or positive controls. 
A thermocycler (Gene Amp PCR System 9700; Ap-
plied Biosystems, Foster City, California, CA, USA) 
was used for the amplification. The PCR was set at 
103 oC for a start run. The PCR was programmed to 
run at 94 oC for 5 min, and then a cycle of 35 runs 
comprising 94 oC for 1 min, 55 oC for 1min, 72 oC for 
1 min followed by a run at 72 oC for 7 min. Storage 
of the mixture was at 4 oC until needed. The ampli-
fied PCR products were separated by check gel 
electrophoresis. The separated DNA fragments 
were visualized by staining the gel with ethidium 
bromide for 15 min and then de-stained in water 
for 15 min. The DNA bands were viewed by illumi-
nation with UV light and images photographed.  
2.4. Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
From the PCR results, three test strains (cp305, 
342, 12218-2) were used to represent three geno-
type groups (cpa and etx, cpa and cpb2, cpa and cpe 
respectively). The protein profiles of these were 
determined in parallel with C. perfringens B and EE 
strains and the run calibrated on a protein ladder 
(Rainbow Molecular Weight Markers). The SDS-
PAGE was run with 1X SDS buffer at 30mA for 90 
min. The protein molecular marker consisted of 10 
min boiled mixture of 5 µl marker, 5 µl H2O, 10 µl 
2X SDS buffer. Protein was extracted from the bac-
terial strains by boiling. After running, the gel was 
stained in coomasie blue solution for 20 min and 
destained three times, rinsed in sterile water twice 
and left in sterile water for 24 h and dried with a 
slab gel dryer for band to be visible. 
3. Results 
All 12 strains possess the cpa gene while the itx 
gene was absent in all strains. Ten strains carry two 
toxin gene types while two strains C. perfringens 
12473 and 12872 have the cpa gene only. The cpb2 
gene is second in occurrence in the strains. Strains 
that carry the same toxin gene combination are 
296, 305, and 341 (etx and cpa), 304, 306, 12218-2 
and 12218-3 (cpb2 and cpa), 309 and 342 (cpe and 
cpa), 12473 and 12872 (cpa only), and 10754 (cpb 
and cpa) (Table 1). Plates 1 and 2 identified the var-
ious C. perfringens toxinotype as obtained by gel 
electrophoresis. Only two strains; 305 and 342 had 
similar protein profile (data not shown). 
4. Discussion 
The twelve C. perfringens veterinary strains had the 
cpa gene and one of the other major toxin genes 
except itx. Two isolates however had cpa gene only 
(12473 from a calf and 12872 from a dog) which 
implied these produced only the CPA toxin. It was 
not clear whether the CPA of the C. perfringens 
was responsible for the disease in these animals 
more so that the symptoms as documented in the 
laboratory data file for the isolates were those of 
enterotoxemia or whether other factors including 
other Clostridium spp were involved. The role of 
CPA in animal diseases cannot be neglected as ex-
perimental evidences have implicated the CPA tox-
in in yellow lamb disease, enteritis, abomasitis and 
malignant edema in cattle, goat, pigs and sheep 
STRAINS etx cpb2 itx cpa cpe cpb 
296 + _ _ + _ _ 
304 _ + _ + _ _ 
305 + _ _ + _ _ 
306 _ + _ + _ _ 
309 _ _ _ + + _ 
341 + _ _ + _ _ 
342 _ _ _ + + _ 
10754 _ _ _ + _ + 
12218-2 _ + _ + _ _ 
12218-3 _ + _ + _ _ 
12473 _ _ _ + _ _ 
12872 _ _ _ + _ _ 
Table 1: Toxin gene types in C. perfringens.  
+; present 
-; absent  
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LANE M: DNA Marker 
LANE B: +VE Control 
LANE EE: +VE Control 
LANE 1: C perf 304 
LANE 2: C perf 305 
LANE 3: C perf 306 
LANE 4: C perf 309 
LANE 5: C perf 341 
LANE 6: C perf 342 
LANE N:-VE Control 
LANE M: DNA Marker 
LANE B: +VE Control 
LANE EE: +VE Control 
LANE 1:C perf 10754 
LANE 2:C perf 12218-2 
LANE 3:C perf 12218-3 
LANE 4:C perf 12473 
LANE 5:C perf 12872 
LANE 6:C perf 296 
LANE N:-VE Control 
Plate 1: PCR gel electrophoresis of C. perfringens toxin genes. Lanes M, B and EE represent the DNA marker, C. 
perfringens B and EE respectively. The negative control is lane N while the test strains are in lanes 1-6. Lanes 1-6 
(all test strains) is positive for cpa (alpha, 324 bps). Lanes 2 and 5 (305 and 341 respectively) are positive for etx 
(epsilon, 655bps). Lanes 1 and 3 (304 and 306) are positive for cpb2 (beta2, 567bps). Lanes 4 and 6 (309 and 342 
respectively) are positive for cpe (enterotoxin, 233bps). 
Plate 2: PCR gel electrophoresis of C. perfringens toxin genes. Lanes M, B and EE represent the DNA marker, C. 
perfringens B and EE respectively. The negative control is lane N while the test strains are in lanes 1-6. Lanes 1-6 
(all test strains) positive for cpa (alpha, 324 bps), Lane 6 (296) is positive for etx (epsilon, 655bps), Lane 2 and 3 
(12218-2 and 12218-3 respectively) are positive for cpb2 (beta2, 567bps). Lane 1 (10754) is positive for cpb (beta, 
196). 
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(Roeder et al., 1988; Choi et al., 2003; Fernandez 
and Uzal, 2005).  
Considering that the cpa gene was present in all C. 
perfringens the presence of another toxin gene as 
detected in other isolates may be indicative of their 
role in the veterinary diseases or death of the ani-
mals. The above is significant; though cpa roles in 
gas gangrene in humans and yellow lamb disease in 
sheep are well established, its involvement in dis-
eases in other animals remains subjective (Awad et 
al., 2001; Uzal et al., 2010).  Nine of the 12 isolates 
were from sick animals while three were isolated 
from dead dog and calves. The isolates from the 
decease animals were 309 (dog), 305 and 342 
(calves). C. perfringens 309 had the cpe gene that 
codes for toxin E which has been implicated in re-
current diarrhea in dogs (Weese et al., 2001).  
The isolates from dog carry the same gene types 
with some of the cattle’s. For instance strain 296 
from dog has same toxin gene as strains 305 and 
341 from cattle. Similarly, strain 309 (dog) and 342 
(cattle) have genotype combination of cpa-cpe. The 
epidemiological significance of this was not readily 
obvious except that cattle and dog may constitute 
pool of the cpe gene from which humans may ac-
quire infection. This may be the case for non-food-
borne gastroenteritis due to type A C. perfringens 
enterotoxin (CPE) producer which also occur in ani-
mals especially dogs (Collie and McClane, 1998; 
Sparks et al., 2001). 
The multiplex PCR analysis of toxin genes makes it 
easier to detect toxinotypes amongst C. perfringens 
isolates. This occludes the need for elaborate toxin 
assays which may involve the use of animals or cell 
lines. From this study it was easy to predict toxin 
group of the isolates without necessarily assaying 
for toxin. Consequently, isolates 296, 305 and 341 
may belong to either type B or D, isolates 309, 342, 
12473 and 12872 are of type A. Isolate 10754 is 
either type B or C, however isolates producing cpb2 
may not be easily placed as additional investiga-
tions are required. Of importance is that presump-
tive assessment of toxinotype can be determined 
by toxin gene detection. 
5. Conclusion 
This study was done with stock cultures of C. 
perfringens with the only available information of 
source and clinical conditions of the animals. The 
study had aptly shown that PCR determination of 
toxin gene type in C. perfringens may be predictive 
of the toxin responsible for disease in animals. 
 
References 
Awad MM, Ellenor DM, Bod RL, Emmins JJ, Rood JI (2001) Syner-
gistic effects of alpha-toxin and perfringolysin O in Clostridium 
perfringens-mediated gas gangrene. Infection and Immunity 69: 
7904-7910. 
Choi YK, Kang MS, Yoo HS, Lee DY, Lee HC, Kim DY (2003) Clostridi-
um perfringens type A myonecrosis in a horse in Korea. Journal of 
Veterinary Medical Sciences 65: 1245-1247. 
Cole ST, Canard B (1997) In Rood JI, McClane BA, Songer JG, Titball 
RW, Eds. Structure, organization and evolution of the genome of 
Clostridium perfringens. The clostridia: molecular biology and 
pathogenesis. London: Academic Presss, pp. 49-63. 
Collie RE, McClane BA (1998) Evidence that the enterotoxin gene 
can be episomal in Clostridium perfringens isolates associated with 
non-food-borne human gastrointestinal diseases. Journal of Clini-
cal Microbiology 36: 30-36.  
Daly R, Rotert L (2007) Clostridium perfringens infections in baby 
calves. Extension Extra, South Dakota Cooperative Extension Ser-
vice. ExEx 11022 Dec 2007 Veterinary Service. 
Deguchi A, Miyamoto K, Kuwahara T, Yasuhiro M, Ikuko K, Jihong L 
et al. (2009) Genetic characterization of type A enterotoxigenic 
Clostridium perfringens strains. PLoS One 4:  e5598. 
Dray T (2004) Clostridium perfringens type A and beta2 toxin asso-
ciated with enterotoxemia in a 5-week-old goat. Canadian Veteri-
nary Journal 45: 251- 253. 
Fernandez MME, Uzal FA (2005) Morphological and physiological 
changes induced by Clostridium perfringens type A a-toxin in the 
intestine of sheep. American Journal Veterinary Research 66:251-
255. 
Ferrarezi MC, Cardoso TC, Dutra IS (2008) Genotyping of Clostridi-
um perfringens isolated from calves with neonatal diarrhea. Anaer-
obe 4: 328-331. 
Fisher DJ, Fernandez-Miyakawa ME, Sayeed S, et al. (2006) Dis-
secting the contributions of Clostridium perfringens type C toxins 
to lethality in the mouse intravenous injection model. Infection 
and Immunity 74: 5200-5210. 
Hendriksen SW, van Leengoed LA, Roest HI, van Nes A (2006) Neo-
natal diarrhea in pigs: alpha- and beta 2-toxin produced by Clos-
tridium perfringens. Tijdschr Diergeneeskd 131: 910-913. 
Itodo AE, Ike RO (1990) Enterotoxaemia in sheep and cattle in the 
Jos Plateau, Nigeria. Tropical Veterinarian 8: 120-122. 
Itodo AE, Umoh JU, Adekeye JO, Odugbo MO, Haruna G, Sugun MY 
(2009) Field trial of sodium alginate-adsorbed Clostridium 
perfringens types C and D toxoid against clostridial enterotoxemia 
in sheep. Israel Journal of Veterinary Medicine 64(1): 2-5. 
Jores J, Derocher AE, Staubach C, Aschfalk A (2008) Occurrence 
and prevalence of Clostridium perfringens in polar bears from 
Svalbard, Norway. Journal of Wild Diseases 44: 155-158. 
Li J, Miyamoto K, McClane BA (2007) Comparison of virulence 
plasmids among Clostridium perfringens type E isolates. Infection 
and Immunity  75: 1811-1819. 
McClane BA, Lyerly DL, Wilkins TD (2006) In: Fischetti RPN-VA, 
 132 
Egwari et al., South Asian J Exp Biol; 4 (3): 127-132; 2014 
Feretti JJ, Portnoy DA, Rood JI, Eds. Enterotoxic clostridia: Clostridi-
um perfringens type A and Clostridium difficile. Gram positive 
pathogens. Washington DC: ASM Press  pp. 703-714. 
McClane BA, Uzal FA, Fernandez-Miyakawa M, Lyerly D, Wilkins TD 
(2004) In: Dworkin SFM, Rosenburg E, Schleifer KF, Stackebrandt E, 
Eds. The enterotoxigenic clostridia. The Prokaryotes. New York: 
Springer-Verlag  pp698-752. 
Roeder BL, Chengappa MM, Nagataja TG, Avery TB, Kennedy GA 
(1988) Experimental induction of abdominal tympany, abomasitis, 
and abomasal ulceration by intraruminal inoculation of Clostridi-
um perfringens type A in neonatal calves. American Journal Veteri-
nary Research 49: 201-207. 
Sayeed S, Li J, McClane BA (2007) Virulence plasmid diversity in 
Clostridium perfringens type D isolates. Infection and Immunity 75: 
2391-2398. 
Songer JG (1998) Clostridia diseases of small ruminants. Veterinary 
Research 29: 219-232. 
Songer JG, Miskimins DW (2005) Clostridial abomastitis in calves: 
case report and review of the literature. Anaerobe 11: 290-294. 
Sparks SG, Carman RJ, Sarker MR, McClane BA (2001) Genotyping 
of enterotoxigenic Clostridium perfringens fecal isolates associat-
ed with antibiotic-associated diarrhea and food poisoning in North 
America. Journal Clinical Microbiology 39: 883-888. 
Uzal FA, Kelly WR (1997) The effects of intravenous administration 
of Clostridium perfringens type D epsilon toxin on young goats and 
lambs. Journal of Comparative Pathology 116: 63-71. 
Uzal FA (2004) Diagnosis of Clostridium perfringens intestinal in-
fections in sheep and goats. Anaerobe 10: 135-143. 
Uzal FA, Vidal JE, McClane BA, Gurjar AA (2010) Clostridium 
perfringens toxins involved in mammalian veterinary diseases. The 
Open Toxicology J 3: 24-42. 
Weese JS, Greenwood SJ, Staempfli HR (2001) Recurrent diarrhea 
associated with enterotoxigenic Clostridium perfringens in 2 dogs. 
Canadian Veterinary Journal 2001; 42: 292-294. 
